Setting a diagnostic benchmark for tumor BRCA testing: detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue

Setting a diagnostic benchmark for tumor BRCA testing: detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue – A pilot study

Published:2021-12 Issue: Volume:123 Page:104705
ISSN:0014-4800
Container-title:Experimental and Molecular Pathology
language:en
Short-container-title:Experimental and Molecular Pathology

Author:

Valtcheva Nadejda,Nguyen-Sträuli Bich Doan,Wagner Ulrich,Freiberger Sandra N.,Varga Zsuzsanna,Britschgi Christian,Dedes Konstantin J.,Rechsteiner Markus P.

Funder

University Hospital Zurich

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Molecular Biology,Pathology and Forensic Medicine

Reference28 articles.

1. Integrated genomic analyses of ovarian carcinoma;Bell;Nature.,2011

2. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature.,2005

3. Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women;Cao;BMC Cancer,2019

4. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial;Coleman;Lancet.,2017

5. Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status;Cunningham;Sci. Rep.,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The landscape of BRCA1 and BRCA2 large rearrangements in an international cohort of over 20 000 ovarian tumors identified using next‐generation sequencing;Genes, Chromosomes and Cancer;2023-05-24